Recent News

• 03.10.2025 - Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
• 03.03.2025 - Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
• 01.21.2025 - Publication relating to transparency notification
• 01.21.2025 - Transparency notification BlackRock Inc.
• 01.20.2025 - Publication relating to transparency notifications
• 12.24.2024 - Publication relating to transparency notification
• 12.24.2024 - Transparency notification BlackRock Inc.
• 12.20.2024 - Publication relating to transparency notifications
• 12.13.2024 - Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
• 12.13.2024 - Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Recent Filings

• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.02.2025 - EX-99.1 EX-99.1
• 12.13.2024 - EX-99.1 EX-99.1
• 12.13.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.02.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]